Cargando…
Neuroinflammation and Neuronal Loss Precede Aβ Plaque Deposition in the hAPP-J20 Mouse Model of Alzheimer’s Disease
Recent human trials of treatments for Alzheimer’s disease (AD) have been largely unsuccessful, raising the idea that treatment may need to be started earlier in the disease, well before cognitive symptoms appear. An early marker of AD pathology is therefore needed and it is debated as to whether amy...
Autores principales: | Wright, Amanda L., Zinn, Raphael, Hohensinn, Barbara, Konen, Lyndsey M., Beynon, Sarah B., Tan, Richard P., Clark, Ian A., Abdipranoto, Andrea, Vissel, Bryce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613362/ https://www.ncbi.nlm.nih.gov/pubmed/23560052 http://dx.doi.org/10.1371/journal.pone.0059586 |
Ejemplares similares
-
Goal-Directed Action Is Initially Impaired in a hAPP-J20 Mouse Model of Alzheimer’s Disease
por: Dhungana, Amolika, et al.
Publicado: (2023) -
Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
por: Steffen, Johannes, et al.
Publicado: (2017) -
Chronic Apocynin Treatment Attenuates Beta Amyloid Plaque Size and Microglial Number in hAPP(751)(SL) Mice
por: Lull, Melinda E., et al.
Publicado: (2011) -
Variation in Group Composition Alters an Early-Stage Social Phenotype in hAPP-Transgenic J20 Mice
por: Lanooij, Suzanne D., et al.
Publicado: (2023) -
Neural compensation in presymptomatic hAPP mouse models of Alzheimer's disease
por: Ammassari-Teule, Martine
Publicado: (2020)